Immunization Newsbriefs
Link to Main Page
  Back Search the Site Send Your Feedbck  
Immunization Newsbriefs
Read Current Issue Online
Search Newsbriefs Archives
Subscribe to Email Online
Unsubscribe from Email Online
About NNii
Vaccine Information
Health Professionals
Policy Makers
Read Current Newsbriefs

Chiron Sets Phase III Trial for Meningococcal C Vaccine
Dow Jones Newswire;
Park, Jenny


Chiron Corp. plans to launch this year a phase III trial of its Menjugate vaccine in the United States. The conjugate vaccine to protect against meningococcal C disease has already been approved for use in infants through adults in 24 nations. Chiron noted that Neisseria meningitidis causes approximately 120,000 cases of bacterial meningitis and sepsis annually, with about 3,000 of those cases in the United States.

© Copyright National Network for Immunization Information. The information contained in the National Network for Immunization Information Web site should not be used as a substitute for the medical care and advice of your health care provider. There may be variations in treatment that your health care provider may recommend based on individual facts and circumstances.